⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5345895 | 0.77 | CYP1A2 (0.35) | — | |
| SCHEMBL2511148 | 0.77 | TSHR (0.37) | — | |
| SCHEMBL2136922 | 0.76 | — | — | |
| SCHEMBL27676666 | 0.76 | — | — | |
| SCHEMBL2236622 | 0.74 | — | — | |
| SCHEMBL9807645 | 0.74 | — | — | |
| Water SCHEMBL28060703 | 0.74 | TSHR (0.35) | — | |
| SCHEMBL4259788 | 0.74 | NOS1 (0.38) | — | |
| SCHEMBL1756411 | 0.74 | TSHR (0.30) | — | |
| SCHEMBL27723464 | 0.74 | ALOX15 (0.35) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 89 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113622220-A | Thermal sublimation transfer paper with high production efficiency and preparation method thereof | 苏州吉谷新材料有限公司 | 2021-11-09 | — | — | CN | claimed |
| CN-113622219-A | Thermal sublimation transfer paper with high transfer rate and preparation method thereof | 苏州吉谷新材料有限公司 | 2021-11-09 | — | — | CN | claimed |
| CN-113622221-A | Thermal sublimation transfer printing paper with high transfer rate and high drying speed and preparation method thereof | 苏州吉谷新材料有限公司 | 2021-11-09 | — | — | CN | claimed |
| CN-212758548-U | Dual-cooling and cooling continuous reaction device for urea formation by using Lunatinib mesylate | 南京佰麦生物技术有限公司 | 2021-03-23 | — | — | CN | claimed |
| CN-106573913-A | Acid addition salts of Trk inhibiting compounds | 小野药品工业株式会社 | 2017-04-19 | — | — | CN | claimed |
| CN-101550136-B | Diarylurea derivatives and application thereof used for preparing anti-neoplastic medicament | UNIV SHENYANG PHARMACEUTICAL | 2013-06-19 | — | — | CN | claimed |
| CN-101550136-A | Diarylurea derivatives and application thereof used for preparing anti-neoplastic medicament | UNIV SHENYANG PHARMACEUTICAL (CN) | 2009-10-07 | — | — | CN | claimed |
| EP-3728487-B1 | METHOD OF REMOVING POLYMERIC MATERIAL COMPRISING HETEROATOMS FROM A SURFACE USING COMPOSITIONS INCLUDING A KETO-ESTER COMPOUND | FOURTH PRINCIPLE LLC (US) | 2025-07-02 | — | — | EP | disclosed |
| EP-3708633-B1 | METHOD FOR RECOVERY OF CRUDE OIL | ECOLAB USA INC (US) | 2025-03-19 | — | — | EP | disclosed |
| US-11370996-B2 | Compositions including keto-ester compounds and methods of using the same | FOURTH PRINCIPLE, LLC (US) | 2022-06-28 | — | — | US | disclosed |
| CN-113622220-A | Thermal sublimation transfer paper with high production efficiency and preparation method thereof | 苏州吉谷新材料有限公司 | 2021-11-09 | — | — | CN | disclosed |
| CN-113622221-A | Thermal sublimation transfer printing paper with high transfer rate and high drying speed and preparation method thereof | 苏州吉谷新材料有限公司 | 2021-11-09 | — | — | CN | disclosed |
| CN-113622221-A | Thermal sublimation transfer printing paper with high transfer rate and high drying speed and preparation method thereof | 苏州吉谷新材料有限公司 | 2021-11-09 | — | — | CN | disclosed |
| EP-1140086-A1 | N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Du Pont Pharmaceuticals Company (US) | 2001-10-10 | — | — | EP | disclosed |
| EP-1140087-A1 | N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Du Pont Pharmaceuticals Company (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000035449-A1 | N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-06-22 | — | — | WO | disclosed |
| WO-2000035451-A1 | N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-06-22 | — | — | WO | disclosed |
| WO-2000035452-A1 | N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-06-22 | — | — | WO | disclosed |
| WO-2000035453-A1 | N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-06-22 | — | — | WO | disclosed |
| WO-2000035454-A1 | N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-06-22 | — | — | WO | disclosed |